21576-27-2 Usage
Uses
Used in Pharmaceutical Synthesis:
Ethyl 1-Methyl-2-oxopiperidine-3-carboxylate is used as a synthetic intermediate for the development of various pharmaceuticals. Its unique chemical structure allows it to be incorporated into the synthesis process, potentially enhancing the properties and effectiveness of the resulting compounds.
Used in Organic Compound Synthesis:
In the field of organic chemistry, Ethyl 1-Methyl-2-oxopiperidine-3-carboxylate serves as a key component in the synthesis of a range of organic compounds. Its versatility and reactivity make it a valuable building block for creating new molecules with diverse applications.
Used in Medicinal Chemistry Research:
Ethyl 1-Methyl-2-oxopiperidine-3-carboxylate is used as a research tool in medicinal chemistry to explore its potential to modify the structure and function of biologically active compounds. This can lead to the discovery of new therapeutic agents and a better understanding of the underlying mechanisms of drug action.
Used in Drug Development:
In the pharmaceutical industry, Ethyl 1-Methyl-2-oxopiperidine-3-carboxylate is utilized in drug development to create novel drug candidates. Its ability to modify the properties of other compounds can contribute to the design of more effective and targeted therapies for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 21576-27-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,5,7 and 6 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 21576-27:
(7*2)+(6*1)+(5*5)+(4*7)+(3*6)+(2*2)+(1*7)=102
102 % 10 = 2
So 21576-27-2 is a valid CAS Registry Number.
21576-27-2Relevant academic research and scientific papers
Novel spiroheterocycles by aziridination of α-methylene-γ- and -δ-lactams
Loreto, M. Antonietta,Migliorini, Antonella,Tardella, P. Antonio,Gambacorta, Augusto
, p. 2365 - 2371 (2008/02/08)
New potentially bioactive α-spiroaziridino-γ- and -δ-lactams have been prepared by treatment of α-methylene-γ- and -δ-lactams with ethyl N-([(4-nitrophenyl)sulfonyl]oxy)-carbamate (NsONHCO2Et) in the presence of CaO. These compounds, through reductive aziridine ring opening, can be intermediates for the synthesis of α- and β-aminolactams, which are useful as conformational constraints in peptides. The above procedure has been successfully extended to one α-methyleneoxindole to obtain a new spirooxindole derivative, a potential precursor of natural alkaloids. Wiley-VCH Verlag GmbH & Co. KGaA, 2007.
